Role of Family History for Alzheimer Biomarker Abnormalities in the Adult Children Study
Author(s) -
Chengjie Xiong,
Catherine M. Roe,
Virginia Buckles,
Anne M. Fagan,
David Holtzman,
David A. Balota,
Janet M. Duchek,
Martha Storandt,
Mark A. Mintun,
Elizabeth Grant,
Abraham Z. Snyder,
Denise Head,
Tammie L.S. Benzinger,
Joseph Mettenburg,
John G. Csernansky,
John C. Morris
Publication year - 2011
Publication title -
archives of neurology
Language(s) - English
Resource type - Journals
eISSN - 1538-3687
pISSN - 0003-9942
DOI - 10.1001/archneurol.2011.208
Subject(s) - fractional anisotropy , pittsburgh compound b , biomarker , cerebrospinal fluid , magnetic resonance imaging , diffusion mri , medicine , alzheimer's disease , splenium , positron emission tomography , white matter , dementia , psychology , neuroscience , disease , genetics , biology , radiology
To assess whether family history (FH) of Alzheimer disease (AD) alone influences AD biomarker abnormalities.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom